Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Frederik Weber

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The British Journal of Radiology|March 31, 2023
Test-retest, inter- and intra-rater reproducibility of size measurements of focal bone marrow lesions in MRI in patients with multiple myelomaMarkus Wennmann, Martin Grözinger, Vivienn Weru, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
Scientific Reports|December 1, 2022
Asynchronous calibration of quantitative computed tomography bone mineral density assessment for opportunistic osteoporosis screening: phantom-based validation and parameter influence evaluationStephan Skornitzke, Neha Vats, Taisiya Kopytova, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
Gut|March 23, 2019
<i>RSPO2</i> gene rearrangement: a powerful driver of β-catenin activation in liver tumoursThomas Longerich, Volker Endris, Olaf Neumann, et al.
Investigative Radiology|May 31, 2022
Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Marrow Characterization From Whole-Body MRI: A Multicentric Feasibility StudyMarkus Wennmann, André Klein, Fabian Bauer, et al.
Leukemia|December 22, 2025
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myelomaMartin Grözinger, Muriel Schlanke, Jana Gröne, et al.
Investigative Radiology|October 18, 2022
Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter StudyMarkus Wennmann, Peter Neher, Nikolas Stanczyk, et al.
Academic Radiology|July 10, 2025
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell DisordersMarkus Wennmann, Jessica Kächele, Arvin von Salomon, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The British Journal of Radiology|March 31, 2023
Test-retest, inter- and intra-rater reproducibility of size measurements of focal bone marrow lesions in MRI in patients with multiple myelomaMarkus Wennmann, Martin Grözinger, Vivienn Weru, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.
Scientific Reports|December 1, 2022
Asynchronous calibration of quantitative computed tomography bone mineral density assessment for opportunistic osteoporosis screening: phantom-based validation and parameter influence evaluationStephan Skornitzke, Neha Vats, Taisiya Kopytova, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
Gut|March 23, 2019
<i>RSPO2</i> gene rearrangement: a powerful driver of β-catenin activation in liver tumoursThomas Longerich, Volker Endris, Olaf Neumann, et al.
Investigative Radiology|May 31, 2022
Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Marrow Characterization From Whole-Body MRI: A Multicentric Feasibility StudyMarkus Wennmann, André Klein, Fabian Bauer, et al.
Leukemia|December 22, 2025
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myelomaMartin Grözinger, Muriel Schlanke, Jana Gröne, et al.
Investigative Radiology|October 18, 2022
Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter StudyMarkus Wennmann, Peter Neher, Nikolas Stanczyk, et al.
Academic Radiology|July 10, 2025
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell DisordersMarkus Wennmann, Jessica Kächele, Arvin von Salomon, et al.
Pageof 5